Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?
Sign Up to like & getrecommendations! Published in 2024 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-024-06719-5
Abstract: Preclinical studies are essential for effectively evaluating TAT radiopharmaceuticals. Given the current suboptimal supply chain of these radionuclides, animal studies must be refined to produce the most translatable TAT agents with the greatest clinical potential.… read more here.
Keywords: meet needs; preclinical strategies; radiopharmaceutical development; strategies radiopharmaceutical ... See more keywords